Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Tao, Yan Fang ^a   Xu, Li Xiao ^a   Lu, Jun ^a   Cao, Lan ^a   Li, Zhi Heng ^a   Hu, Shao Yan ^a   Wang, Na Na ^a   Du, Xiao Juan ^b   Sun, Li Chao ^c   Zhao, Wen Li ^a   Xiao, Pei Fang ^a   Fang, Fang ^a   Li, Yan Hong ^a   Li, Gang ^a   Zhao, He ^a   Li, Yi Ping ^a   Xu, Yun Yun ^a   Ni, Jian ^d   Wang, Jian ^a   Feng, Xing ^a   Pan, Jian ^a   more..

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b The 5th Hospital of Chinese PLA   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Metallothionein III; Methylation; Pediatric acute myeloid leukemia; Tumor suppressor

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; CASPASE 10; CASPASE 7; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CD5 ANTIGEN; CULLIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ECTODYSPLASIN A; FAS ASSOCIATED DEATH DOMAIN PROTEIN; HEAT SHOCK PROTEIN 70; HEMOGLOBIN; METALLOTHIONEIN III; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 3; PROTEIN BCL 2; PROTEIN KINASE C ALPHA; PROTEIN NOXA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SOMATOSTATIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; GROWTH INHIBITOR; NERVE PROTEIN; PRIMER DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CD34 SELECTION; CELL PROLIFERATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LENTIVIRINAE; LEUKEMIA CELL LINE; LEUKOCYTE COUNT; MALE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; THROMBOCYTE COUNT; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; GENETICS; INFANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; TUMOR CELL LINE;

ADOLESCENT; BASE SEQUENCE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; DNA PRIMERS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 84902932663     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-182     Document Type: Article

References (39)

1. Appelbaum FR, Baer MR, Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Kraut EH, Maslak P, Millenson M, Miller CB, Saba HI, Stone R, Tallman MS. NCCN practice guidelines for Acute Myelogenous Leukemia. Oncology (Williston Park) 2000, 14:53-61.
2. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989, 74:395-408.
3. Basu I, Cordovano G, Das I, Belbin TJ, Guha C, Schramm VL. A transition state analogue of 5'-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers. J Biol Chem 2007, 282:21477-21486.
4. Mann MR, Bartolomei MS. Epigenetic reprogramming in the mammalian embryo: struggle of the clones. Genome Biol 2002, 3:2. REVIEWS1003.
5. Agrawal S, Unterberg M, Koschmieder S, ZurStadt U, Brunnberg U, Verbeek W, Buchner T, Berdel WE, Serve H, Muller-Tidow C. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 2007, 67:1370-1377.
6. Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys 2013, 67:501-513.
7. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
8. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998, 395:89-93.
9. Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001, 47:1183-1189.
10. Willman CL. Targeted AML therapy: new biologic paradigms and therapeutic opportunities. Leukemia 2001, 15:690-694.
11. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood 2001, 97:2823-2829.
12. Miftakhova R, Sandberg T, Hedblom A, Nevzorova T, Persson JL, Bredberg A. DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation. Anticancer Res 2012, 32:4715-4722.
13. Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t (8;21) acute myeloid leukemia. Febs J 2013, 281:1123-1131.
14. Deshpande AJ, Bradner J, Armstrong SA. Chromatin modifications as therapeutic targets in MLL-rearranged leukemia. Trends Immunol 2012, 33:563-570.
15. Bernt KM, Armstrong SA. Targeting epigenetic programs in MLL-rearranged leukemias. Hematology Am Soc Hematol Educ Program 2011, 2011:354-360.
16. Tabe Y, Konopleva M, Kondo Y, Contractor R, Jin L, Ruvolo V, Tsutsumi-Ishii Y, Miyake K, Miyake N, Ohsaka A, Nagaoka I, Issa JP, Andreeff M. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter. Ann Hematol 2006, 85:689-704.
17. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa S. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014, 28:241-247.
18. Weissmann S, Alpermann T, Grossmann V, Kowarsch A, Nadarajah N, Eder C, Dicker F, Fasan A, Haferlach C, Haferlach T, Kern W, Schnittger S, Kohlmann A. Landscape of TET2 mutations in acute myeloid leukemia. Leukemia 2012, 26:934-942.
19. Ajjimaporn A, Swinscoe J, Shavali S, Govitrapong P, Ebadi M. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res Bull 2005, 67:466-475.
20. Howells C, West AK, Chung RS. Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain. Febs J 2010, 277:2931-2939.
21. Ma F, Wang H, Chen B, Wang F, Xu H. Metallothionein 3 attenuated the apoptosis of neurons in the CA1 region of the hippocampus in the senescence-accelerated mouse/PRONE8 (SAMP8). Arq Neuropsiquiatr 2011, 69:105-111.
22. Carrasco J, Penkowa M, Giralt M, Camats J, Molinero A, Campbell IL, Palmiter RD, Hidalgo J. Role of metallothionein-III following central nervous system damage. Neurobiol Dis 2003, 13:22-36.
23. Lee SJ, Koh JY. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 2010, 3:30.
24. Lowy AM, Clements WM, Bishop J, Kong L, Bonney T, Sisco K, Aronow B, Fenoglio-Preiser C, Groden J. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006, 66:4734-4741.
25. Smith E, Drew PA, Tian ZQ, De Young NJ, Liu JF, Mayne GC, Ruszkiewicz AR, Watson DI, Jamieson GG. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer 2005, 4:42.
26. Deng D, El-Rifai W, Ji J, Zhu B, Trampont P, Li J, Smith MF, Powel SM. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis 2003, 24:25-29.
27. Olek A, Oswald J, Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 1996, 24:5064-5066.
28. Cheng Y, Geng H, Cheng SH, Liang P, Bai Y, Li J, Srivastava G, Ng MH, Fukagawa T, Wu X, Chan AT, Tao Q. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 2010, 70:6516-6526.
29. Yan-Fang T, Jian N, Jun L, Na W, Pei-Fang X, Wen-Li Z, Dong W, Li P, Jian W, Xing F, Jian P. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC medical genetics 2013, 14:74.
30. Jian P, Li ZW, Fang TY, Jian W, Zhuan Z, Mei LX, Yan WS, Jian N. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol 2011, 4:20.
31. Juang HH, Chung LC, Sung HC, Feng TH, Lee YH, Chang PL, Tsui KH. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Prostate 2013, 73:1495-1506.
32. Yan-Fang T, Dong W, Li P, Wen-Li Z, Jun L, Na W, Jian W, Xing F, Yan-Hong L, Jian N, Jian P. Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int 2012, 12:40.
33. Tao YF, Lu J, Du XJ, Sun LC, Zhao X, Peng L, Cao L, Xiao PF, Pang L, Wu D, Wang N, Feng X, Li YH, Ni J, Wang J, Pan J. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer 2012, 12:619.
34. Zhang X, Tang N, Hadden TJ, Rishi AK. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813, 2011:1978-1986.
35. Lu H, Huang H. FOXO1: a potential target for human diseases. Curr Drug Targets 2011, 12:1235-1244.
36. Monsalve M, Olmos Y. The complex biology of FOXO. Curr Drug Targets 2011, 12:1322-1350.
37. Fu Z, Tindall DJ. FOXOs, cancer and regulation of apoptosis. Oncogene 2008, 27:2312-2319.
38. Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002, 277:47928-47937.
39. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 2000, 20:8969-8982.